🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
To investigate the feasibility of delivering oral azacitidine (CC-486) as a...
Status
Withdrawn
Location
Yale Comprehensive Cancer Center
Start Date
2023-11
Trial ID
NCT06180863
Treatments Being Tested
Rollover study supporting hematological disorder indications from Celgene s...
Status
Completed
Location
Local Institution - 101
Start Date
2015-10-22
Trial ID
NCT02494258
Treatments Being Tested
The purpose of this study is to determine whether the combination therapy o...
Status
Terminated
Location
Palo Verde Hematology Oncology
Start Date
2015-10-09
Trial ID
NCT02546986
Treatments Being Tested
The purpose of this study is to evaluate the safety and efficacy of CC-486 ...
Status
Completed
Location
Winship Cancer Institute of Emory University
Start Date
2015-02-13
Trial ID
NCT02269943
Treatments Being Tested
The purpose of this study is to evaluate the efficacy and safety of Oral Az...
Status
Active Not Recruiting
Location
Local Institution - 0031
Start Date
2022-08-19
Trial ID
NCT05413018
Background: Mature T-cell malignancies (TCMs) are a rare group of cancers ...
Status
Completed
Location
National Institutes of Health Clinical Center
Start Date
2020-12-17
Trial ID
NCT04447027
To identify the maximum tolerated dose (MTD) of oral azacitidine on differe...
Status
Terminated
Location
National Cancer Center Hospital East
Start Date
2013-07
Trial ID
NCT01908387
Treatments Being Tested
Evaluation of the Efficacy and Safety of Oral Azacitidine plus Best Support...
Status
Completed
Location
Alta Bates Comprehensive Cancer Center
Start Date
2013-04-26
Trial ID
NCT01566695
Treatments Being Tested
The purpose of this study is to evaluate the effect of moderate or severe l...
Status
Terminated
Location
Local Institution - 0083
Start Date
2024-07-12
Trial ID
NCT05209295
Treatments Being Tested
This study is a multicentric, open-label, randomized phase 3 trial. The stu...
Status
Completed
Location
Local Institution - 41822
Start Date
2018-11-06
Trial ID
NCT03703375
Treatments Being Tested